ORMP 8-K: Legal settlement

Filed with the SEC on · accession 0001213900-26-122239

ORMP filed a 8-K (current report) with the SEC on Nov 19, 2026. Oramed Pharmaceuticals settled a Delaware Chancery Court class action challenging its bylaws governing stockholder action by written consent. The stock moved -4.1% by the first close after the filing.

Summary of the filing

Oramed Pharmaceuticals settled a Delaware Chancery Court class action challenging its bylaws governing stockholder action by written consent. The company amended its bylaws to moot the action and agreed to pay plaintiff's counsel $125,000 in attorneys' fees and expenses.

Key details

Attorneys' fees and expenses paid to plaintiff's counsel$125K
Defendant/registrantOramed Pharmaceuticals Inc.
President and ceoNadav Kidron

How ORMP stock reacted

Close before

$3.89

Nov 18, 2026

First close after

-4.11%

$3.73

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for ORMP, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for ORMP?

Click here

Frequently asked questions

What did ORMP file with the SEC on Nov 19, 2026?

ORMP filed a 8-K (Legal settlement). Oramed Pharmaceuticals settled a Delaware Chancery Court class action challenging its bylaws governing stockholder action by written consent. The company amended its bylaws to moot the action and agreed to pay plaintiff's counsel $125,000 in attorneys' fees and expenses.

What does a legal settlement mean for ORMP stock?

A settlement removes uncertainty; the stock often reacts to whether the amount is bigger or smaller than investors expected.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

How did ORMP stock react to this filing?

ORMP closed at $3.89 before the filing and $3.73 on Nov 19, 2026 (-4.11%).

Other ORMP SEC filings

Get alerts when ORMP files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days